Hepatitis C virus infection, substance use and mental illness among homeless youth: A review

AIDS

Volumn 19, Issue SUPPL. 3, 2005, Pages

  Nyamathi, Adeline M ^a   Christiani, Ashley ^b   Windokun, Folasade ^a   Jones, Tonia ^a   Strehlow, Aaron ^a   Shoptaw, Steve ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Los Angeles County Department of Public Health Substance Abuse Prevention and Control Program   (United States)

Author keywords

Hepatitis C; Homeless youth; Mental illness; Substance use

Indexed keywords

HEPATITIS A VACCINE; HEPATITIS B VACCINE;

ACTIVE IMMUNIZATION; ALCOHOL ABUSE; ATTENTION DEFICIT DISORDER; CHILD HEALTH CARE; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DRUG DEPENDENCE TREATMENT; HARM REDUCTION; HEALTH CARE NEED; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; MENTAL DISEASE; MENTAL HEALTH SERVICE; PATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SEXUAL BEHAVIOR; SUBSTANCE ABUSE; VULNERABLE POPULATION;

EID: 27944432968     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000192068.88195.27     Document Type: Review

References (52)

1. The Urban Institute. A new look at homelessness in America. The prevalence of homelessness among adolescents in the United States. 1 February 2000. Available at: http://www.urban.org/url.cfm?ID:900302
2. Ringwalt CL, Greene JM, Robertson MJ, McPheeters M. The prevalence of homelessness among adolescents in the United States. Am J Public Health 1998;88:1325-1329.
3. Hammer H, Finkelhor D, Sedlak AJ. Runaway/thrown away children: national estimates and characteristics. Washington, DC: US Department of Justice, Office of Juvenile Justice and Delinquency Prevention; 2002.
4. US Census Bureau. Census 2000. Available at: http://www.census.gov/main/ www/cen2000.html. 2001.
5. Bring LA Home. Homeless in LA: Final research report for the 10-year plan to end homelessness in Los Angeles County. September 2004. Available at: http://bringlahome.org/docs/HILA_Final.PDF.
6. Gleghorn AA, Marx R, Vittinghoff E, Katz MH. Association between drug use patterns and HIV risks among homeless, runaway and street youth in Northern California. Drug Alcohol Depend 1998;51:219-227.
7. Unger JB, Kipke MD, Simon TR, Montgomery SB, Johnson CJ. Homeless youths and young adults in Los Angeles; prevalence of mental health problems and the relationship between mental health and substance abuse disorders. Am J Commun Psychol 1997; 25:371-394.
8. Whitbeck LB, Hoyt DR, Bao W-N. Depressive symptoms and co-occurring depressive symptoms, substance abuse, and conduct problems among runaway and homeless adolescents. Child Dev 2000; 71:721-732.
9. Kral AH, Molnar BE, Booth RE, Watters JK. Prevalence of sexual risk behavior and substance use among runaway and homeless adolescents in San Francisco, Denver, and New York City. Int J STD AIDS 1997; 8:109-117.
10. Greene JM, Ennett ST, Ringwalt CL. Substance use among runaway and homeless youth in three national samples. Am J Public Health 1997; 87:229-235.
11. Shelter Partnership. Report on transitional housing for emancipated foster youth in Los Angeles County 1997. Available at: http://www. shelterpartnership.org/publications/efyexec.pdf.
12. Greene JM, Ringwalt CL, Kelly JE, Iachan R, Cohen Z. Youth with runaway, throwaway, and homeless experiences: prevalence, drug use, and other at-risk behaviors. Research Triangle Park, NC: Research Triangle Institute; 1995.
13. Kipke MD, O'Connor S, Palmer R, Mackenzie RG. Street youth in Los Angeles. Profile of a group at high risk for human immunodeficiency virus infection. Arch Pediatr Adolesc Med 1995; 149:513-519.
14. Dachner N, Tarasuk V. Homeless "squeegee kids": food insecurity and daily survival. Soc Sci Med 2002; 54:1039-1049.
15. Wagner LS, Carlin L, Cauce AM, Tenner A. A snapshot of homeless youth in Seattle: their characteristics, behaviors and beliefs about HIB protective strategies. J Commun Health 2001; 26:219-232.
16. Barry PJ, Ensign J, Lippek SH. Embracing street culture: fitting health care into the lives of street youth. J Transcult Nurs 2002; 2:145-152.
17. Ge X, Conger RD, Lorenz FO, Simons RL. Parents' stressful life events and adolescent depressed mood. J Health Soc Behav 1994; 35:28-44.
18. Wilens TE, Biederman J, Spencer TJ, Frances RJ. Comorbidity of attention-deficit hyperactivity and psychoactive substance use disorders. Hosp Commun Psychiatry 1994; 45:421-423; 435.
19. Garfein RS, Ouellet L, Des Jarlais D, Kerndt P, Strathdee S, Swartzendruber A, et al. HIV and hepatitis C virus (HCV) prevention for new injection drug users (IDUs): an assessment of opportunities for intervention. In: National HIV Prevention Conference. Hyatt Regency Atlanta Hotel, Atlanta, GA, 27-30 July 2003 [Abstract no. T3-A0703].
20. Beech BM, Myers L, Beech DJ. Hepatitis B and C infections among homeless adolescents. Family Commun Health 2002; 25:28-29.
21. Hudson SM, Wagner KD, Kerndt P. Hepatitis A and hepatitis B virus prevalence and history of vaccination among younger injection drug users in Los Angeles. Presented at the APHA Annual Meeting. San Francisco, CA, 16-19 November 2003.
22. De Rosa CJ, Montgomery SB, Kipke MD, Iverson E, Ma JL, Unger JB. Service utilization among homeless and runaway youth in Los Angeles, California: rates and reasons. Adolesc Health 1999; 24:449-458.
23. Reiss G, Keeffe EB. Hepatitis vaccination in patients with chronic liver disease. Aliment Pharmacol Ther 2004; 19:715-727.
24. Magura S, Nwakeze PC, Rosenblum A, Joseph H. Substance misuse and related infectious diseases in a soup kitchen population. Substance Use Misuse 2000; 35:551-583.
25. Shukla NB, Poles MA. Hepatitis B virus infection: co-infection with hepatitis C virus, hepatitis D virus, and human immunodeficiency virus. Clin Liver Dis 2004; 8:445-460.
26. Keeffe EB. Vaccination against hepatitis A and hepatitis B in chronic liver disease. Viral Hepatitis Rev 1999; 5:77-78.
27. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341:556-562.
28. Lifson AR, Halcon LL. Substance abuse and high-risk needle-related behaviors among homeless youth in Minneapolis: implications for prevention. Semin Pediatr Infect Dis 2003; 14:12-19.
29. Stein JA, Nyamathi A. Correlates of hepatitis C virus infection in homeless men: a latent variable approach. Drug Alcohol Depend 2004; 75:89-95.
30. Carter M. Saliva may have infectious amounts of HCV in presence of high HCV viral load and gum disease. Clinical Care Options Hepatitis News Report 2005. Available at: http://clinicaloptions.com/hep/news/news_NAM_140.asp.
31. Haley RW, Fischer RP. Commercial tattooing as a potentially important source of hepatitis C infection. Clinical epidemiology of 626 consecutive patients unaware of their hepatitis C serologic status. Medicine 2001; 80:134-151.
32. Noell J, Rohde P, Ochs L, Yovanoff P, Alter MJ, Schmid S, et al. Incidence and prevalence of Chlamydia, herpes and viral hepatitis in a homeless adolescent population. STD 2001; 28:4-10.
33. Thorpe LE, Quellet LJ, Levy JR, Williams IT, Monterroso ER. Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999. J Infect Dis 2000; 182:1588-1594.
34. Nyamathi A, Dixon E, Robbins W, Wiley D, Leake B, Gelberg L. Risk factors for Hepatitis C virus infection among injecting and non-injecting homeless and impoverished adults. J Gen Intern Med 2002; 17:134-143.
35. Sherman KE, Rouster SD, Chung RT, Rajicic N. Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis 2002; 34:831-837.
36. Hall CS, Charlebois ED, Hahn JA, Moss AR, Bangsberg DR. Hepatitis C virus infection in San Francisco's HIV-infected urban poor. J Gen Intern Med 2004; 19:357-365.
37. Sulkowski MS, Mast EE, Seeff LB, Thomas DL. Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clin Infect Dis 2000; 30(Suppl. 1):S77-S84.
38. Bonacini M, Puoti M. Hepatitis C in patients with human immunodeficiency virus infection: diagnosis, natural history, meta-analysis of sexual and vertical transmission, and therapeutic issues. Arch Intern Med 2000; 160:3365-3373.
39. Lewden C, Salmon D, Morlat P, Bevilacqua S, Jougla E, Bonnet F, et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol 2004; 23:1-10.
40. Greub G, Ledergerber B, Battegay M, Grob P, Perrin L, Furrer H, et al. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 2000; 356:1800-1805.
41. Centers for Disease Control and Prevention (CDC). Hepatitis B vaccination for injection drug users - Pierce County, Washington, 2000. MMWR 2001; 50:388-390.
42. Asarnow JR, Jaycox LH, Duan N, LaBorde AP, Rea MM, Murray P, et al. Effectiveness of equality improvement intervention for adolescent depression in primary care clinics: a randomized controlled trial. AMA 2005; 293:311-319.
43. Rotheram-Borus MJ, Lee M, Leonard N, Lin YY, Franzke L, Turner B, Lightfoot M. Four-year behavioral outcomes of an intervention for parents living with HIV and their adolescent children. AIDS 2003; 17:1217-1225.
44. Riggs DS, Rukstalis M, Volpicelli JR, Kalmanson D, Foa EB. Demographic and social adjustment characteristics of patients with comorbid posttraumatic stress disorder and alcohol dependence: potential pitfalls to PTSD treatment. Addict Behav 2003; 28:1717-1730.
45. National Institute on Drug Abuse (NIDA). Prevalence of drug use in the Washington, DC, metropolitan area homeless and transient population: 1991. Rockville, MD: US DHHS; 1993.
46. Cherpitel CJ. Screening for alcohol problems in the U.S. general population: comparison of the CAGE, RAPS4, and RAPS4-QF by gender, ethnicity, and service utilization. Rapid Alcohol Problems Screen. Alcohol Clin Exp Res 2002; 11:1686-1691.
47. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, et al. The fifth edition of the addiction severity index. J Subst Abuse Treatment 1992; 9:199-213.
48. Caravalho J, Saylor CR. An evaluation of a nurse case managed program for children with diabetes. Pediatric Nurs 2000; 26:296-300; 328.
49. Martino S, Carroll K, Kostas D, Perkins J, Rounsaville B. Dual diagnosis motivational interviewing: a modification of motivational interviewing for substance-abusing patients with psychotic disorders. J Subst Abuse Treatment 2002; 23:297-308.
50. McCambridge J, Strang J. The efficacy of single-session motivational interviewing in reducing drug consumption and perceptions of drug-related risk and harm among young people: results from a multi-site cluster randomized trial. Addiction 2004; 99:39-52.
51. Dunn C, Deroo L, Rivara FP. The use of brief interventions adapted from motivational interviewing across behavioral domains: a systematic review. Addiction 2001; 96:1725-1742.
52. American Academy of Child and Adolescent Psychiatry (AACAP). Practice parameters for the assessment and treatment of children and adolescents with substance use disorders. J Am Acad Child Adolesc Psychiatry 1997; 36(10Suppl.): 140S-156S.